These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Plasmapheresis in the treatment of four cases of Guillain-Barré syndrome (acute form). Zerbi D; Celano I; Forlani G; Garelli S; Mosconi L; Valbonesi M Ital J Neurol Sci; 1981 Dec; 2(4):331-6. PubMed ID: 7333823 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome. Lin JH; Tu KH; Chang CH; Chen YC; Tian YC; Yu CC; Hung CC; Fang JT; Yang CW; Chang MY Transfus Apher Sci; 2015 Feb; 52(1):78-83. PubMed ID: 25544386 [TBL] [Abstract][Full Text] [Related]
26. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group. Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342 [TBL] [Abstract][Full Text] [Related]
27. Guillain Barre syndrome-electrodiagnostic features and therapeutic observations. Shankar V; Bhanu K; Sayeed ZA J Assoc Physicians India; 1995 Oct; 43(10):670-2. PubMed ID: 8773000 [TBL] [Abstract][Full Text] [Related]
28. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Korinthenberg R; Mönting JS Arch Dis Child; 1996 Apr; 74(4):281-7. PubMed ID: 8669925 [TBL] [Abstract][Full Text] [Related]
29. Prognosis in severe Guillain-Barré syndrome. Cole GF; Matthew DJ Arch Dis Child; 1987 Mar; 62(3):288-91. PubMed ID: 3566320 [TBL] [Abstract][Full Text] [Related]
30. [Guillain-Barre syndrome in children in 2009-2014 years]. Stasiak K; Wesołowska E; Kroczka S Przegl Lek; 2016; 73(3):167-9. PubMed ID: 27349047 [TBL] [Abstract][Full Text] [Related]
31. [The treatment of the Guillain-Barré syndrome in childhood by plasmapheresis]. Hernández González A; Rubio Quiñones F; Quintero Otero S; Cozar Navarro L; Cañibano MA; Capote Huelva FJ; Alvarez C; Pantoja Rosso S An Esp Pediatr; 1993 Sep; 39(3):240-2. PubMed ID: 8250439 [TBL] [Abstract][Full Text] [Related]
32. Guillain-Barre syndrome--1985. A review with personal insights. Allen JR Minn Med; 1986 May; 69(5):263-7. PubMed ID: 3736531 [No Abstract] [Full Text] [Related]
33. Outcome in severe pediatric Guillain-Barré syndrome after immunotherapy or supportive care. Graf WD; Katz JS; Eder DN; Smith AJ; Chun MR Neurology; 1999 Apr; 52(7):1494-7. PubMed ID: 10227643 [TBL] [Abstract][Full Text] [Related]
34. Treatment of the Guillain-Barré syndrome by plasmapheresis. Osterman PO; Fagius J; Säfwenberg J; Danersund A; Wallin BG; Nordesjö LO Arch Neurol; 1982 Mar; 39(3):148-54. PubMed ID: 7065932 [TBL] [Abstract][Full Text] [Related]
35. [Guillain-Barré syndrome and plasma exchange]. Raphael JC; Elkharrat D; Chevret S; Vercken JB; Chastang C; Gajdos P Ann Med Interne (Paris); 1990; 141(7):593-6. PubMed ID: 2085236 [No Abstract] [Full Text] [Related]
36. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Urtasun M; López de Munain A; Carrera N; Martí-Massó JF; López de Dicastillo G; Mozo C Ann Pharmacother; 1992 Jan; 26(1):32-3. PubMed ID: 1606342 [TBL] [Abstract][Full Text] [Related]
37. Guillain-Barré syndrome, pregnancy, and plasmapheresis. Clifton ER J Am Osteopath Assoc; 1992 Oct; 92(10):1279-82. PubMed ID: 1459875 [TBL] [Abstract][Full Text] [Related]
39. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome]. Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643 [TBL] [Abstract][Full Text] [Related]
40. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. McKhann GM; Griffin JW; Cornblath DR; Mellits ED; Fisher RS; Quaskey SA Ann Neurol; 1988 Apr; 23(4):347-53. PubMed ID: 3382169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]